Surgery Partners receives ‘buy’ rating — 5 key notes

Nine analysts gave Nashville, Tenn.-based Surgery Partners a “buy” rating, according to The Cerbat Gem.

Advertisement

Here are five key notes:

1. The analysts have an average 12-month price target of $20.86.

2. On Jan. 17, 2017, Jeffries Group gave the company a $24 price target.

3. Surgery Partners opened Jan. 19, 2017, trading at $18 per share.

4. The company’s market cap. totals $872.87 million.

5. The P/E ratio is 92.78.

More articles on surgery centers:
Christ Hospital’s dispute with St. Elizabeth Healthcare over $24M ASC may wage on for years
Auburn Planning Board to consider surgery center application: 5 things to know
Massachusetts Department of Public Health updates DON regulations for existing freestanding ASCs: 4 key notes

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • The number of ASCs per 100,000 Medicare beneficiaries varied widely across states and geographies in 2024, according to a MedPAC…

  • Investments in outpatient ventures are expanding ASCs become more integral to hospital and health systems’ throughput and financial growth—with some…

Advertisement

Comments are closed.